EGFR and breast cancer: Our data do not support the published hypothesis of an overexpression-induced mechanism for ligand-independent EGFR homodimerization [62] because EGFR expression in SKBR3 cells is even lower than in normal breast tissue, as is generally the case in human breast cancers [35].